Economic Consequences of Anti-HCV Treatment of Patients Diagnosed Through Screening in Italy: A Prospective Modelling Analysis.

Appl Health Econ Health Policy · 2022 · PMC8752541 · PMID 34636024

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The associated per-patient cost by disease stage post‐SVR was adapted to a decreasing trend in time based on real-life data on costs incurred in the first, second, and third year following SVR or SVR from ILD.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.